Lymphoma Clinical Trials

A listing of Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1671 clinical trials
None
Study of Plasma NGS for Assessment Characterization Evaluation of Patients With ALK Resistance

ALK-positive lung cancer is a subtype of lung cancer which carries a change in a gene called ALK (anaplastic lymphoma kinase). There are now many drugs for patients with ALK-positive lung cancer

brigatinib
liquid biopsy
lung carcinoma
alectinib
  • 0 views
  • 01 Aug, 2021
None
The Influence of Extracorporeal Photopheresis on Skin Sclerosis

after receiving FDA approval in 1988. Extracorporeal photopheresis was initially used for the treatment of T-cell lymphoma. Since its introduction, indications for initiating ECP were continuously

  • 0 views
  • 21 Feb, 2021
  • 1 location
None
The ASSESS National Multi-center Prospective Cohort

The ASSESS national multi-center prospective cohort (Assessment of Systemic complications (Signs) and Evolution in Sjgren's Syndrome "SS") was set up in 2006 thanks to a grant of the French Ministry of Health. Fifteen centers for autoimmune diseases consecutively included consecutive patients with Primary Sjgren's Syndrome "pSS" fulfilling American-European Consensus Criteria …

  • 1 views
  • 24 Jan, 2021
  • 3 locations
None
Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome

The investigators designed a compassionate basis phase II study for refractory/relapsed mycosis fungoides/Sezary syndrome consisting of alemtuzumab (Campath) for primary evaluation of overall response and time to relapse. Other goals to consider are toxicity and time to new therapy.

mycosis
renal function test
campath
mycosis fungoides and sezary syndrome
sezary syndrome
  • 54 views
  • 07 Nov, 2020
  • 1 location
None
EEG Encephalopathy Patterns in Immune Effectors Cells-associated Neurotoxicity Syndrome (ICANS)Lay Language

Immune effectors cells-associated neurotoxicity syndrome (ICANS) is one of the most clearly defined acute toxicities after CAR-T cells infusion. The investigators conducted a prospective cohort study of all patients who received CAR T cell infusions on the hematology department from Montpellier University Medical Center. Each patient was assessed between the …

  • 0 views
  • 16 Sep, 2021
  • 1 location
None
Head and Neck Cancer in Children: A Retrospective Study

The aim of the study is to identify demographic characteristics, various histopathologies, and site preferences for each disease entity of malignant head and neck tumors in pediatric oncology patients & treatment outcomes in these patients, according to experience at South Egypt Cancer Institute which is the largest referral site in …

neck cancer
head and neck cancer
cancer
neck tumor
  • 0 views
  • 03 Feb, 2021
  • 1 location
None
Visual Outcomes With a Trifocal IOL in Subjects With Open-angle Glaucoma

This study will examine the visual outcomes of subjects undergoing cataract surgery and minimally invasive glaucoma surgery with the implantation of a trifocal intraocular lens.

  • 0 views
  • 15 Apr, 2021
  • 1 location
None
Determination of Blood Tumor Cells

Magnetic nanoparticles coated with anti-EpCAM or anti-CD52 antibodies will be tested ex-vivo in patients blood .

lymphoma
hematologic malignancy
cancer
  • 0 views
  • 13 Oct, 2021
  • 1 location
None
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors

This study uses a double autologous peripheral blood stem cell rescue (PBSC) following dose-intensive chemotherapy for the treatment of high-risk pediatric solid tumors.

soft tissue sarcoma
sarcoma
germ cell tumor
metastasis
recurrent disease
  • 76 views
  • 07 Nov, 2020
  • 1 location
None
A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients

This study is designed to evaluate the untreated NSCLC patients. After participants have accepted chemotherapy, radiotherapy, and immunotherapy, the investigators used the next generation sequence technology (NGS) to construct immune repertoire to detective variation of patients' immune state and to monitor patients' therapeutic effect. The investigators are aim to explore …

lung carcinoma
pembrolizumab
cancer chemotherapy
stage iv non-small cell lung cancer
  • 24 views
  • 28 Mar, 2021
  • 1 location